Tectonic Therapeutic (TECX) Net Cash Flow (2017 - 2026)
Tectonic Therapeutic (TECX) reported Net Cash Flow of -$17.6 million for Q1 2026, down 110.66% year-over-year from $165.0 million in Q1 2025, and down 20.43% quarter-over-quarter from -$14.6 million in Q4 2025.
Tectonic Therapeutic (TECX) Net Cash Flow (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Net Cash Flow data on file, last reported at -$17.6 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$17.6 million, down 110.66% year-over-year; the trailing twelve-month figure through Mar 2026 was -$69.5 million (down 124.16% YoY), and the FY2025 annual result was $113.1 million, up 0.59% from the prior year.
- Net Cash Flow slipped to -$17.6 million in Q1 2026 per TECX's latest filing, from -$14.6 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $166.4 million in Q2 2024 and troughed at -$29.3 million in Q2 2022.
- A 5-year average of $6.1 million and a median of -$17.6 million in 2026 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2024: Net Cash Flow slumped 343.98% in 2022, then jumped 20973.27% in 2024.
- A 5-year view of Net Cash Flow shows it stood at -$23.6 million in 2022, then surged by 194.96% to $22.4 million in 2023, then sank by 179.8% to -$17.9 million in 2024, then rose by 18.39% to -$14.6 million in 2025, then dropped by 20.43% to -$17.6 million in 2026.
- Business Quant data shows TECX's Net Cash Flow at -$17.6 million in Q1 2026, -$14.6 million in Q4 2025, and -$18.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 664,983.53 |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | -17.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.59 Mn |
| Mar 31, 2026 | -17.59 Mn |
| Dec 31, 2025 | -14.60 Mn |
| Dec 31, 2025 | -14.60 Mn |
| Sep 30, 2025 | -18.44 Mn |
| Sep 30, 2025 | -18.44 Mn |
| Jun 30, 2025 | -18.83 Mn |
| Jun 30, 2025 | -18.83 Mn |
| Mar 31, 2025 | 165.01 Mn |
| Mar 31, 2025 | 165.01 Mn |
| Dec 31, 2024 | -17.89 Mn |
| Dec 31, 2024 | -17.89 Mn |
| Sep 30, 2024 | -26.04 Mn |
| Sep 30, 2024 | -26.04 Mn |
| Jun 30, 2024 | 166.36 Mn |
| Jun 30, 2024 | 166.36 Mn |
| Mar 31, 2024 | -9.95 Mn |
| Mar 31, 2024 | -9.95 Mn |
| Dec 31, 2023 | 22.42 Mn |
| Dec 31, 2023 | 22.42 Mn |